At 𝗘𝗟𝗘 𝗕𝗶𝗼𝘁𝗲𝗰𝗵, we work to ensure that neurodegenerative diseases associated with dementia can be detected before it’s too late.

𝗢𝘂𝗿 𝗺𝗶𝘀𝘀𝗶𝗼𝗻 is to bring 𝗲𝗮𝗿𝗹𝘆 𝗱𝗲𝗺𝗲𝗻𝘁𝗶𝗮 𝗿𝗶𝘀𝗸 𝗱𝗲𝘁𝗲𝗰𝘁𝗶𝗼𝗻 into real-world clinical practice by developing molecular diagnostic kits based on qPCR.

We are committed to a biotechnology that is precise, accessible, and scalable, designed to integrate into population screening programs, primary care, and personalized healthcare.

𝗢𝘂𝗿 𝘃𝗮𝗹𝘂𝗲𝘀:
🔅𝗖𝗼𝗺𝗺𝗶𝘁𝗺𝗲𝗻𝘁 𝘁𝗼 𝘀𝗰𝗶𝗲𝗻𝘁𝗶𝗳𝗶𝗰 𝘁𝗿𝘂𝘁𝗵 → We research with rigor, transparency, and responsibility, always prioritizing evidence.
🔅𝗙𝗲𝗺𝗮𝗹𝗲 𝗹𝗲𝗮𝗱𝗲𝗿𝘀𝗵𝗶𝗽 𝗮𝗻𝗱 𝗲𝗾𝘂𝗶𝘁𝘆 → We foster an inclusive environment, with women at the forefront and real opportunities for all.
🔅𝗛𝘂𝗺𝗮𝗻-𝗰𝗲𝗻𝘁𝗲𝗿𝗲𝗱 𝗰𝗮𝗿𝗲 → We develop technology with empathy, focused on the well-being of patients, families, and communities.
🔅𝗖𝗼𝘂𝗿𝗮𝗴𝗲 𝘁𝗼 𝗶𝗻𝗻𝗼𝘃𝗮𝘁𝗲 → We challenge the status quo with solid science and a bold vision for change.
🔅 𝗛𝗼𝗻𝗲𝘀𝘁𝘆 𝗮𝗻𝗱 𝗲𝘁𝗵𝗶𝗰𝘀 → We make coherent, ethical, and sustainable decisions, always putting social impact first.
🔅𝗢𝗽𝗲𝗿𝗮𝘁𝗶𝗼𝗻𝗮𝗹 𝗲𝘅𝗰𝗲𝗹𝗹𝗲𝗻𝗰𝗲 → We apply the highest scientific, regulatory, and quality standards at every stage of the project.

ELE Biotech is a deep tech company founded and led by Laura Vallés Saiz (PhD) and Elena Calvo Cantero, two women with complementary backgrounds in science and innovation.
Born in Spain with a global outlook, ELE Biotech is working to transform the future of dementia diagnostics.
If you share our purpose and want to be part of this journey — let’s connect.

ELE Biotech

Org chart

Teams

Offices